Mucosal T cells from patients with IBD express high levels of Smad7, an inhibitor of TGFβ1 signaling, suggesting that dysregulated TGFβ1 signaling might have a role in the pathogenesis of IBD.(44). Here, SMAD7 is linked to inflammatory bowel disease.